GlaxoSmithKline | GSK

Stock Price
1,476.00
Daily Change
7.00 0.48%
Monthly
7.50%
Yearly
-10.63%
Q3 Forecast
1,468.03

Peers Price Chg Day Year Date
AbbVie 212.56 -0.44 -0.21% 9.95% Sep/05
Alcon AG 64.08 0.62 0.98% -19.15% Sep/05
Almirall 10.96 -0.16 -1.44% 27.89% Sep/05
Amgen 283.64 3.54 1.26% -11.49% Sep/05
argenx SE 639.80 8.40 1.33% 31.21% Sep/05
AstraZeneca 12,090.00 -98.00 -0.80% -4.89% Sep/06
Bayer 28.16 -0.42 -1.47% -1.83% Sep/06
Biogen 140.67 0.73 0.52% -30.02% Sep/05
Bristol-Myers Squibb 47.14 0.45 0.96% -3.28% Sep/05
Fresenius Medical Care 41.99 0.28 0.67% 16.83% Sep/06
Fresenius 46.82 -0.36 -0.76% 39.22% Sep/06
Genmab 1,751.50 6.50 0.37% -5.83% Sep/05
Gilead Sciences 115.05 2.28 2.02% 46.10% Sep/05
Galapagos 28.44 1.84 6.92% 11.53% Sep/06
GRIFOLS 12.30 0.02 0.16% 32.17% Sep/05
GlaxoSmithKline 1,476.00 7.00 0.48% -10.63% Sep/05
Hikma Pharmaceutical 1,720.00 -3.00 -0.17% -12.07% Sep/05
Eli Lilly 727.21 -15.70 -2.11% -19.48% Sep/05
Lonza 577.40 -0.80 -0.14% 7.68% Sep/05
Merck 109.55 1.05 0.97% -35.52% Sep/06
Merck 84.71 0.66 0.79% -28.14% Sep/05
Novartis 103.98 0.06 0.06% 5.46% Sep/05
Novo Nordisk A/S 350.00 -10.50 -2.91% -60.30% Sep/05
Orion 65.90 -1.10 -1.64% 36.67% Sep/05
Pfizer 24.88 0.34 1.39% -12.95% Sep/05
Philips 23.80 0.02 0.08% -12.63% Sep/06
Recordati 54.05 -0.25 -0.46% 5.16% Sep/05
Regeneron Pharmaceuticals 573.38 6.16 1.09% -49.30% Sep/05
Roche Holding 274.20 -1.50 -0.54% 2.62% Sep/06
Sanofi 79.50 0.54 0.68% -24.83% Sep/06
Smith & Nephew 1,416.00 6.00 0.43% 18.15% Sep/05
UCB 206.90 2.30 1.12% 28.99% Sep/05

Indexes Price Day Year Date
GB100 9208 -8.67 -0.09% 12.55% Sep/05
EU600 549 -0.88 -0.16% 8.42% Sep/05

GlaxoSmithKline traded at 1,476.00 this Friday September 5th, increasing 7.00 or 0.48 percent since the previous trading session. Looking back, over the last four weeks, GlaxoSmithKline gained 7.50 percent. Over the last 12 months, its price fell by 10.63 percent. Looking ahead, we forecast GlaxoSmithKline to be priced at 1,468.03 by the end of this quarter and at 1,444.38 in one year, according to Trading Economics global macro models projections and analysts expectations.

GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.